Format

Send to

Choose Destination
J Exp Med. 2019 Oct 14. pii: jem.20190945. doi: 10.1084/jem.20190945. [Epub ahead of print]

GM-CSF in inflammation.

Author information

1
The University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia jahami@unimelb.edu.au.
2
Australian Institute for Musculoskeletal Science, The University of Melbourne and Western Health, St Albans, Victoria, Australia.

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has many more functions than its original in vitro identification as an inducer of granulocyte and macrophage development from progenitor cells. Key features of GM-CSF biology need to be defined better, such as the responding and producing cell types, its links with other mediators, its prosurvival versus activation/differentiation functions, and when it is relevant in pathology. Significant preclinical data have emerged from GM-CSF deletion/depletion approaches indicating that GM-CSF is a potential target in many inflammatory/autoimmune conditions. Clinical trials targeting GM-CSF or its receptor have shown encouraging efficacy and safety profiles, particularly in rheumatoid arthritis. This review provides an update on the above topics and current issues/questions surrounding GM-CSF biology.

PMID:
31611249
DOI:
10.1084/jem.20190945

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center